From: Changes in practice patterns affecting in-hospital and post-discharge survival among ACS patients
Variables: | MICH1 n = 814 | MICH2 n = 452 | HARP n = 710 | p-value |
---|---|---|---|---|
Demographics: | Â | Â | Â | Â |
Age | M = 63.8 | M = 65.6 | M = 60.7 | <0.01 |
 | SD = 13.7 | SD = 14.5 | SD = 12.7 |  |
Gender (male) | 510 (62.7%) | 266 (58.9%) | 443 (62.4%) | >0.36 |
Race (white) | 682 (83.8%) | 364 (80.5%) | 606 (85.4%) | >0.09 |
Charlson Index | M = 2.32 | M = 2.69 | M = 2.09 | <0.01 |
Med = 2 | Med = 2 | Med = 2 | Â | Â |
 | Range = 1–10 | Range = 1–12 | Range = 1–12 |  |
Ejection Fraction | Â | Â | Â | <0.01 |
   <35% | 83 (10.2%) | 43 (9.5%) | 75 (10.4%) |  |
   35%–44% | 121 (14.9%) | 46 (10.2%) | 115 (16.0%) |  |
   ≥45% | 396 (48.7%) | 146 (32.3%) | 422 (58.7%) |  |
   missing | 214 (26.3%) | 217 (48.0%) | 107 (14.9%) |  |
No. of Vessels | Â | Â | Â | <0.01 |
   0 | 28 (3.5) | 14 (3.3) | 66 (11.0) |  |
   1 | 196 (24.6) | 84 (20.0) | 207 (34.3) |  |
   2 | 180 (22.6) | 80 (19.0) | 155 (25.7) |  |
   3 | 392 (49.2) | 243 (57.7) | 175 (29.0) |  |
Invasive Procedures and Treatments: | Â | Â | Â | Â |
None | 200 (24.6) | 142 (31.4) | 72 (10.5) | <0.01 |
CATH | 614 (75.4) | 312 (68.4) | 638 (89.5) | <0.01 |
PCI | 216 (26.5) | 136 (30.1) | 342 (48.2) | <0.01 |
CABG | 185 (22.7) | 74 (16.4) | 158 (22.3) | <0.01 |
Medications in Hospital: | Â | Â | Â | Â |
ACEIs & ARBs | 161 (19.8) | 154 (34.7) | 407 (57.3) | <0.01 |
Beta-Blockers | 186 (24.1) | 186 (41.2) | 500 (70.4) | <0.01 |
Aspirin | 498 (61.2) | 307 (67.9) | 614 (96.5) | <0.01 |
Thrombolytics | 480 (59.0) | 278 (61.5) | 77 (10.9) | <0.01 |
Medications at Hospital Discharge: | Â | Â | Â | Â |
ACEIs & ARBs | 161 (19.8) | 154 (34.7) | 407 (57.3) | <0.01 |
Beta-Blockers | 186 (24.1) | 186 (41.2) | 500 (70.4) | <0.01 |
Aspirin | 498 (61.2) | 307 (67.9) | 614 (96.5) | <0.01 |